TrialClinical lung cancer2016

Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer.

Jared M Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.